Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt European and international experts discuss the way forward in stem-cell research and development 12 maj 2010Press releaseAdvanced therapies European Medicines Agency gives new temporary treatment recommendations for Fabrazyme 23 april 2010Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 19-22 April 2010 23 april 2010Press releaseHuman European Medicines Agency recommends revocation of marketing authorisations for bufexamac 22 april 2010Press releaseMedicines Novartis Europharm Ltd withdraws its marketing authorisation application for Joulferon (albinterferon alfa-2b) 19 april 2010Press release Public statement on concerns over unregulated medicinal products containing stem cells 16 april 2010NewsAdvanced therapies Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 13-15 April 2010 16 april 2010Press releaseVeterinary European Medicines Agency sees no safety concerns with the Rotarix oral vaccine 26 marts 2010Press releaseMedicines European Medicines Agency's Management Board emphasises the importance of the European medicines network 26 marts 2010Press releaseCorporate Sun Pharmaceutical Industries Europe B.V. withdraws its marketing authorisation application for Repaglinide SUN (repaglinide) 25 marts 2010Press release 1 … 288 289 290 291 292 Page 292 of 380 293 294 295 296 … 380
European and international experts discuss the way forward in stem-cell research and development 12 maj 2010Press releaseAdvanced therapies
European Medicines Agency gives new temporary treatment recommendations for Fabrazyme 23 april 2010Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 19-22 April 2010 23 april 2010Press releaseHuman
European Medicines Agency recommends revocation of marketing authorisations for bufexamac 22 april 2010Press releaseMedicines
Novartis Europharm Ltd withdraws its marketing authorisation application for Joulferon (albinterferon alfa-2b) 19 april 2010Press release
Public statement on concerns over unregulated medicinal products containing stem cells 16 april 2010NewsAdvanced therapies
Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 13-15 April 2010 16 april 2010Press releaseVeterinary
European Medicines Agency sees no safety concerns with the Rotarix oral vaccine 26 marts 2010Press releaseMedicines
European Medicines Agency's Management Board emphasises the importance of the European medicines network 26 marts 2010Press releaseCorporate
Sun Pharmaceutical Industries Europe B.V. withdraws its marketing authorisation application for Repaglinide SUN (repaglinide) 25 marts 2010Press release